A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Abstract Text:

C Härnryd,L Bjerkenstedt,B Gullberg,

Twenty schizophrenic women participated in a double-blind comparison of melperone (300 mg daily) and placebo lasting 4 weeks. All the patients received milieu treatment. Two patients in the melperone and four in the placebo group were removed from the study due to unsatisfactory therapeutic response. In the melperone group, there were significant reductions in psychotic morbidity. In the placebo group, there were occasional significant reductions of psychotic morbidity during but not at the end of treatment. The melperone-treated patients exhibited significantly lower morbidity scores than the placebo group after treatment for two and four weeks. The melperone group demonstrated significantly more adverse reactions than placebo-treated patients at the end of the study. The results support the view that melperone exerts an antipsychotic effect. The study is consistent with the opinion that milieu therapy should be combined with neuroleptics to achieve an optimal result in the treatment of an acute phase of schizophrenia.

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Publishing Authors By Initials

C Härnryd,L Bjerkenstedt,B Gullberg,

For similar behavioral disciplines and activities: psychotherapy: socioenvironmental therapy: milieu therapy: therapeutic community research abstracts see: behavioral disciplines and activities: psychotherapy: socioenvironmental therapy: milieu therapy: therapeutic community research

PUBMED ID PMID:

MEDLINE DATE:

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 352

Page Numbers: 40-7

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1989

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Keywords Mesh Terms:

KEYWORDS: Therapeutic Community

MESH TERMS: drug therapy

Chemical & Substance for Abstract: A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Information

Substance Name: metylperon

Registry Number: 3575-80-2

Grant and Affiliation Information for A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.

AFFILIATION: Department of Psychiatry and Psychology, Karolinska Institute, Sweden.

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward Related Publications

• A CPRS subscale to assess mental symptoms in workers exposed to jet fuel--some methodological considerations.
• A backprojection filtering algorithm for a spatially varying focal length collimator.
• A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.
• Concerning the mechanism of the mammalian conversion of tryptophan into kynurenine, kynurenic acid, and nicotinic acid.
• Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
• Employing components-of-variance to evaluate forensic breath test instruments.
• Global regulation of the interphase microtubule system by abundantly expressed op18/stathmin.
• How to keep that stemmy-ness: stem cells in the spotlight.
• Impact of postal and telephone reminders on pick-up rates of unclaimed e-prescriptions.
• In vivo and in vitro release of vitamin B12-binding protein characterized by large molecular size.
• Measuring regional changes in the diastolic deformation of the left ventricle of SHR rats using microPET technology and hyperelastic warping.
• Neuronal pathways leading to the kidney.
• New Zealand's Breath and Blood Alcohol Testing Programs: Further data analysis and forensic implications.
• Normal and pathological NCAT image and phantom data based on physiologically realistic left ventricle finite-element models.
• Normal range curves for the intrauterine growth of the biparietal diameter.
• Op18/Stathmin counteracts the activity of overexpressed tubulin-disrupting proteins in a human leukemia cell line.
• Possible antimicrobial function of the large molecular size vitamin B12-binding protein.
• Re-programmable tumour cells: cytokines from the immune system assume new roles with the help of stem cells.
• Reconstruction and visualization of fiber and laminar structure in the normal human heart from ex vivo diffusion tensor magnetic resonance imaging (DTMRI) data.
• Tomographic reconstruction using an adaptive tetrahedral mesh defined by a point cloud.
• Tryptophan metabolism; concerning the mechanism of the mammalian conversion of tryptophan into kynurenine, kynurenic acid, and nicotinic acid.